BSE: 544611
MAHAMAYA LIFESCIENCES LIMITED
Manufactures and sells agrochemical crop protection and healthcare products from a facility in Dahej, Gujarat, with corporate operations in Gurugram. FY26 consolidated revenue from operations was ₹328.87 crore, up 24.5% year-on-year, with consolidated profit after tax of ₹1,652.33 lakhs and standalone PAT of ₹1,672.08 lakhs. The company describes itself as an integrated agrochemical company and is ISO 9001:2015 certified with GMP-compliant manufacturing. It received the 'Company of the Year – Medium Scale' award from the Pesticides Manufacturers & Formulators Association of India at ICSCE 2026 in Dubai. FY26 cost composition shows employee costs at 2.5% of revenue and other operating expenses at 3.8%, with capital expenditure at 2.7%. The company listed on the BSE SME platform on 18 November 2025 through an IPO that raised ₹64.28 crore, with proceeds allocated to a new technical manufacturing plant, warehouse/machinery, equipment purchases, working capital, and general corporate purposes. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. Agrochemical crop protection and healthcare products. SME-listed agrochemical manufacturer with FY26 revenue of ₹328.87 crore and a new technical manufacturing plant under construction
Exhibit 1: Financial summary, FY26–FY26 (all audited; no estimate years)
| ₹ crore · consolidated | FY26 |
|---|---|
| Revenue | 329 |
| EBITDA (ex other income) | — |
| margin % | — |
| Owners' profit | — |
| EPS, as reported (₹) | 8.33 |
| ROE % · ROCE % | — · 25.2 |
| Debt / equity (x) | — |
| Cash from operations | (30) |
| Capex | (9) |
Exhibit 2: Quarterly performance, last 2 quarters
| ₹ crore | Q2 FY26 | Q4 FY26 |
|---|---|---|
| Revenue | 163 | 166 |
| Profit before tax | 11 | 12 |
| Net profit | — | — |
| EPS (₹) | 4.71 | 3.72 |
Exhibit 3: Peers — basic industry group, by market cap
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| UPL LIMITED | 43,856 | 21.5 | 1.06 | 6.0 | 5.4 | 5.5 | 6.0 | 16.3 |
| PI INDUSTRIES LTD | 31,709 | 27.2 | 2.82 | 15.0 | 11.8 | 14.5 | 8.0 | 25.3 |
| SUMITOMO CHEM INDIA LTD | 16,936 | 29.2 | 4.99 | 21.1 | 16.0 | 20.8 | 4.1 | 28.9 |
| BAYER CROPSCIENCE LTD | 14,727 | 21.4 | 4.97 | — | 23.2 | 27.3 | — | 22.7 |
| SHARDA CROPCHEM LTD. | 5,819 | 9.3 | 1.86 | 4.7 | 21.7 | 25.2 | 17.1 | 20.5 |
| DHANUKA AGRITECH LTD | 3,842 | 13.2 | 2.74 | 8.6 | 21.2 | 27.0 | 12.7 | 27.4 |
| RALLIS INDIA LTD | 3,610 | 22.5 | 2.13 | 12.2 | 9.7 | 12.5 | — | 0.9 |
| NACL INDUSTRIES LIMITED | 2,645 | 221.4 | 3.87 | 33.4 | 0.7 | 1.4 | 5.9 | 11.3 |
Exhibit 4: Where the company sits in its group
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 20.3 | 19.0 | 14 of 24 | 44% |
| ROCE | 18.8 | 12.5 | 6 of 29 | 82% |
| Market cap | 400 | 1362 | 21 of 29 | 29% |
Exhibit 5: Filings of the last 90 days, with the measured price reaction
| Date · filing | Category | Importance | Next day % | 5-day % |
|---|---|---|---|---|
| 9 Oct 2026 · Mahamaya Lifesciences executives featured in AgroPages interview | business updates | low | — | — |
| 8 Oct 2026 · Quarterly certificate for dematerialisation of securities filed with BSE | compliance | minimal | — | — |
| 30 Sept 2026 · Board reshuffle: Founder becomes Chairman, son elevated to MD | management changes | medium | — | — |
| 30 Sept 2026 · Mahamaya Lifesciences 24th AGM: All 9 resolutions passed with 100% approval | board shareholder meetings | low | — | — |
| 29 Sept 2026 · Mahamaya Lifesciences 24th AGM held; 9 resolutions put to vote | board shareholder meetings | low | — | — |
| 28 Sept 2026 · Trading Window Closed from Oct 1 for Half Year Results Declaration | compliance | minimal | — | — |
| 8 Sept 2026 · Mahamaya Lifesciences announces completion of 24th AGM notice dispatch | compliance | minimal | — | — |
| 7 Sept 2026 · Annual Report FY26: Revenue up 24.5%, PAT rises 29% post BSE SME listing | results | high | — | — |
| 7 Sept 2026 · 24th AGM on Sept 29, 2026 - director changes and salary revisions | board shareholder meetings | low | — | — |
| 7 Sept 2026 · Mahamaya Lifesciences 24th AGM notice published in newspapers | compliance | minimal | — | — |
How to read this document
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions | an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
Sources, method and disclosures
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.